In rodents, EPO protects against streptozotocin (STZ) induced type 1 diabetes by reversing STZ-mediated β-cell destruction, an activity that is abrogated with EpoR knockout in pancreatic islet, and is protective against diabetes in the db/db mouse model of type 2 diabetes [156,170]. The gene discussed is EPO; the disease is type 1 diabetes mellitus.